Related references
Note: Only part of the references are listed.ΔNp63 is an ectodermal gatekeeper of epidermal morphogenesis
R. Shalom-Feuerstein et al.
CELL DEATH AND DIFFERENTIATION (2011)
p63 is a suppressor of tumorigenesis and metastasis interacting with mutant p53
G. Melino
CELL DEATH AND DIFFERENTIATION (2011)
ΔNp630α Is an Oncogene that Targets Chromatin Remodeler Lsh to Drive Skin Stem Cell Proliferation and Tumorigenesis
William M. Keyes et al.
CELL STEM CELL (2011)
Role of ΔNp63γ in Epithelial to Mesenchymal Transition
Jaime Lindsay et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Dual specificity phosphatase 6 (DUSP6) is an ETS-regulated negative feedback mediator of oncogenic ERK signaling in lung cancer cells
Zhenfeng Zhang et al.
CARCINOGENESIS (2010)
ERK2 but Not ERK1 Induces Epithelial-to-Mesenchymal Transformation via DEF Motif-Dependent Signaling Events
Sejeong Shin et al.
MOLECULAR CELL (2010)
TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs
Xiaohua Su et al.
NATURE (2010)
Heat-shock transcription factor HSF1 has a critical role in human epidermal growth factor receptor-2-induced cellular transformation and tumorigenesis
L. Meng et al.
ONCOGENE (2010)
Down-Regulation of DUSP6 Expression in Lung Cancer Its Mechanism and Potential Role in Carcinogenesis
Koji Okudela et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Orai1 and STIM1 Are Critical for Breast Tumor Cell Migration and Metastasis
Shengyu Yang et al.
CANCER CELL (2009)
Loss of ΔNp63α Promotes Invasion of Urothelial Carcinomas via N-Cadherin/Src Homology and Collagen/Extracellular Signal-Regulated Kinase Pathway
Hiroshi Fukushima et al.
CANCER RESEARCH (2009)
Mutant p53 Drives Invasion by Promoting Integrin Recycling
Patricia A. J. Muller et al.
CELL (2009)
A Mutant-p53/Smad Complex Opposes p63 to Empower TGFβ-Induced Metastasis
Maddalena Adorno et al.
CELL (2009)
ΔNp63α-dependent expression of Id-3 distinctively suppresses the invasiveness of human squamous cell carcinoma
Koichiro Higashikawa et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Erk1/2 MAP kinases are required for epidermal G2/M progression
Phillip A. Dumesic et al.
JOURNAL OF CELL BIOLOGY (2009)
Regulation of VDR by ΔNp63α is associated with inhibition of cell invasion
Ramakrishna Kommagani et al.
JOURNAL OF CELL SCIENCE (2009)
Inhibition of the c-Abl-TAp63 pathway protects mouse oocytes from chemotherapy-induced death
Stefania Gonfloni et al.
NATURE MEDICINE (2009)
Negative-feedback regulation of FGF signalling by DUSP6/MKP-3 is driven by ERK1/2 and mediated by Ets factor binding to a conserved site within the DUSP6/MKP-3 gene promoter
Maria Ekerot et al.
BIOCHEMICAL JOURNAL (2008)
p63 in epithelial development
E. Candi et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
DUSP6 (MKP3) Null Mice Show Enhanced ERK1/2 Phosphorylation at Baseline and Increased Myocyte Proliferation in the Heart Affecting Disease Susceptibility
Marjorie Maillet et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Snail-induced down-regulation of ΔNp63α acquires invasive phenotype of human squamous cell carcinoma
Koichiro Higashikawa et al.
CANCER RESEARCH (2007)
p63 is essential for the proliferative potential of stem cells in stratified epithelia
Makoto Senoo et al.
CELL (2007)
Phosphatidylinositol-3-OH kinase or RAS pathway mutations in human breast cancer cell lines
Antoinette Hollestelle et al.
MOLECULAR CANCER RESEARCH (2007)
Dusp6 (Mkp3) is a negative feedback regulator of FGF-stimulated ERK signaling during mouse development
Chaoying Li et al.
DEVELOPMENT (2007)
p63 protects the female germ line during meiotic arrest
Eun-Kyung Suh et al.
NATURE (2006)
Wild-type p53 inhibits nuclear factor-κB-Induced matrix metalloproteinase-9 promoter activation:: Implications for soft tissue sarcoma growth and metastasis
Jue Liu et al.
MOLECULAR CANCER RESEARCH (2006)
Tumor-specific p73 up-regulation mediates p63 dependence in squamous cell carcinoma
Maurice Phillip DeYoung et al.
CANCER RESEARCH (2006)
Loss of p63 leads to increased cell migration and up-regulation of genes involved in invasion and metastasis
Christopher E. Barbieri et al.
CANCER RESEARCH (2006)
Continuous ERK activation downregulates anti proliferative genes throughout G1 phase to allow cell-cycle progression
Takuya Yamamoto et al.
CURRENT BIOLOGY (2006)
Differential roles of p63 isoforms in epidermal development: selective genetic complementation in p63 null mice
E. Candi et al.
CELL DEATH AND DIFFERENTIATION (2006)
Src oncogene activates MMP-2 expression via the ERK/Sp1 pathway
LY Kuo et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2006)
p63 regulates an adhesion programme and cell survival in epithelial cells
Danielle K. Carroll et al.
NATURE CELL BIOLOGY (2006)
p63 mediates survival in squamous cell carcinoma by suppression of p73-dependent apoptosis
JW Rocco et al.
CANCER CELL (2006)
p63 deficiency activates a program of cellular senescence and leads to accelerated aging
WM Keyes et al.
GENES & DEVELOPMENT (2005)
DNA-binding and transactivation activities are essential for TAp63 protein degradation
HQ Ying et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
The gene expression signatures of melanoma progression
C Haqq et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Abrogation of DUSP6 by hypermethylation in human pancreatic cancer
SH Xu et al.
JOURNAL OF HUMAN GENETICS (2005)
Tumor predisposition in mice mutant for p63 and p73:: Evidence for broader tumor suppressor functions for the p53 family
ER Flores et al.
CANCER CELL (2005)
Perp is a p63-regulated gene essential for epithelial integrity
RA Ihrie et al.
CELL (2005)
ERK-dependent signaling pathway and transcriptional factor Ets-1 regulate matrix metalloproteinase-9 production in transforming growth factor-beta 1 stimulated glomerular podocytes
SY Liu et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2005)
Matrix metalloproteinase-1 up-regulation by hepatocyte growth factor in human dermal fibroblasts via ERK signaling pathway involves Ets1 and Fli1
M Jinnin et al.
NUCLEIC ACIDS RESEARCH (2005)
ERK1/2 is activated in non-small-cell lung cancer and associated with advanced tumours
S Vicent et al.
BRITISH JOURNAL OF CANCER (2004)
FAK-Src signalling through paxillin, ERK and MLCK regulates adhesion disassembly
DJ Webb et al.
NATURE CELL BIOLOGY (2004)
Both nuclear-cytoplasmic shuttling of the dual specificity phosphatase MKP-3 and its ability to anchor MAP kinase in the cytoplasm are mediated by a conserved nuclear export signal
M Karlsson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Different gene expression patterns in invasive lobular and ductal carcinomas of the breast
HJ Zhao et al.
MOLECULAR BIOLOGY OF THE CELL (2004)
Identification of a gene expression signature associated with recurrent disease in squamous cell carcinoma of the head and neck
MA Ginos et al.
CANCER RESEARCH (2004)
Potential tumor suppressive pathway involving DUSP6/MKP-3 in pancreatic cancer
T Furukawa et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Correlation of expression of BP1, a homeobox gene, with estrogen receptor status in breast cancer
SW Fu et al.
BREAST CANCER RESEARCH (2003)
Targeting ras signalling pathways in cancer therapy
J Downward
NATURE REVIEWS CANCER (2003)
A C-terminal inhibitory domain controls the activity of p63 by an intramolecular mechanism
Z Serber et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Expression of p53 and its homologues in primary and recurrent squamous cell carcinomas of the head and neck
A Weber et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Splicing mutations in TP53 in human squamous cell carcinoma lines influence immunohistochemical detection
W Eicheler et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2002)
Temporal and quantitative regulation of mitogen-activated protein kinase (MAPK) modulates cell motility and invasion
JS Krueger et al.
ONCOGENE (2001)
Hay-Wells syndrome is caused by heterozygous missense mutations in the SAM domain of p63
JA McGrath et al.
HUMAN MOLECULAR GENETICS (2001)
AIS is an oncogene amplified in squamous cell carcinoma
K Hibi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
